Intelligence Profile
Research Papers
Haelan 951, a soy-based flavonoid beverage, has been investigated in a few studies for its potential therapeutic effects. A 2018 study published in PLoS Currents explored the effectiveness of soy products in Duchenne Muscular Dystrophy (DMD). However, specific findings on Haelan 951 were not elaborated, and the study's design and sample size were not detailed.
Another study from 2015 in BMC Complementary and Alternative Medicine examined the effects of Haelan 951 on pancreatic carcinoma cell lines. This in vitro study demonstrated that Haelan 951 could induce growth arrest and apoptosis (programmed cell death) in these cancer cell lines. The specific mechanisms and broader implications for human use were not detailed in the abstract.
A clinical trial (NCT07751029), which has not yet started recruiting, aims to assess Haelan 951's effects on menopause symptoms in peri- and postmenopausal women. However, as it is not yet underway, no results or sample sizes are currently available.
In summary, while there are some in vitro findings and upcoming clinical research, concrete evidence from clinical trials in humans is limited at this stage.
Disclaimer: This summary is for informational purposes only and not intended to provide medical advice. Please consult a healthcare professional for medical concerns.